目的：探究基于渥太华研究应用模式的机器人辅助胃癌根治术临床护理应用方案。方法：前瞻性选 取 2022 年 10 月—2023 年 10 月山西省肿瘤医院收治的 80 例机器人辅助胃癌根治术患者，根据随机数字表法分为 对照组和观察组，对照组（n=40）采用常规护理，观察组（n=40）采用基于渥太华研究应用模式的护理方案，并 比较两组患者的护理效果。结果：观察组术后胃肠道恢复情况优于对照组，差异具有统计学意义（P<0.05），且 观察组护理满意度、CD-RISC 评分及 SF-36 评分均高于对照组，差异具有统计学意义（P<0.05），观察组各时间 段 AAQ-Ⅱ评分低于对照组，差异具有统计学意义（P<0.05）。同时，观察组护理后 3 d、7d 的依从率均高于对照 组，差异具有统计学意义（P<0.05），观察组术后并发症发生率低于对照组，差异具有统计学意义（P<0.05）。 结论：针对机器人辅助胃癌根治术患者开展基于渥太华研究应用模式的护理效果更优，可改善患者负面情绪，提高 护理满意度，降低术后并发症。

Objective: To explore the clinical nursing method of robot-assisted radical gastrectomy based on the Ottawa model of research use. Methods: 80 patients who underwent robot-assisted radical gastrectomy in Shanxi Provincial Cancer Hospital from October 2022 to October 2023 were prospectively selected and divided into the control group and observation group using random number table method. The control group (n=40 cases) received routine nursing, while the observation group (n=40 cases) received nursing plan based on the Ottawa research application model. The nursing effect of the two groups was compared. Results: The postoperative gastrointestinal recovery of the observation group was better than that of the control group, and the difference was statistically significant (P<0.05). The nursing satisfaction, CD-RISC score and SF-36 score of the observation group were higher than those of the control group, and the differences were statistically significant (P<0.05).The AAQ-Ⅱ score in the observation group was lower than that in the control group, and the difference was statistically significant (P< 0.05). Meanwhile, the compliance rate after nursing in the observation group was higher than that in the control group, and the difference was statistically significant (P<0.05). The incidence of postoperative complications in the observation group was lower than that of the control group, and the difference was statistically significant (P<0.05). Conclusion: The nursing effect of patients undergoing robot-assisted radical gastrectomy based on the Ottawa model of research use is better, which could improve nursing satisfaction and reduce postoperative complications.

收稿日期：2023-12-27  录用日期：2024-03-30

Received Date: 2023-12-27  Accepted Date: 2024-03-30 

基金项目：山西省自然科学基金面上项目（2022FDG6394） 

Foundation Item: Natural Science Foundation of Shanxi Province (2022FDG6394) 

通讯作者：杨书姝，Email：342139474@qq.com 

Corresponding Author: YANG Shushu, Email: 342139474@qq.com 

引用格式：屈文清，杨书姝 . 基于渥太华研究应用模式的机器人辅助胃癌根治术临床护理应用方案构建 [J]. 机器人外科学杂志（中 英文），2024，5（4）：710-716. 

Citation: QU W Q, YANG S S. Construction of clinical nursing scheme of robot-assisted radical gastrectomy based on the Ottawa model of research use[J]. Chinese Journal of Robotic Surgery, 2024, 5(4): 710-716.

[1] 郭进 , 詹渭鹏 , 狐鸣 , 等 . 达芬奇机器人“3+1”模式在进展期 远端胃癌根治术中的临床应用 [J]. 机器人外科学杂志 ( 中英文 ), 2022, 3(5): 406-413. 

[2] LI H Q, YUAN H, WAN G Y, et al. Preferences of gastric cancer survivors for follow-up care—a multicenter discrete choice experiment study[J]. Support Care Cancer, 2022, 30(2): 1221-1229. 

[3] Teh S H, Uong S, Lin T Y, et al. Clinical outcomes following regionalization of gastric cancer care in a US integrated health care system[J]. J Clin Oncol, 2021, 39(30): 3364-3376. 

[4] 张丽峰 , 王麦换 , 赵单 , 等 . 接纳承诺疗法在机器人辅助胃癌 根治术后患者中的应用 [J]. 中华现代护理杂志 , 2021, 27(29): 4008-4011. 

[5] Chapin W J, Massa R C, Eads J R. Evolving standards of care for neoadjuvant and adjuvant therapy in esophageal, gastroesophageal junction, and gastric Cancer[J]. Clin Adv Hematol Oncol, 2021, 19(12): 784-793. 

[6] 尚静 , 王锐 , 王静 . 循证综合护理干预预防腹腔镜胃癌根治术 后患者下肢深静脉血栓形成的效果 [J]. 血栓与止血学 , 2022, 28(3): 1041-1042, 1044. 

[7] 蒋祈 , 张鹏 , 陶凯雄 . 美国国立综合癌症网络临床实践指南 : 胃 癌 (2022.V2) 更新解读 [J]. 临床外科杂志 , 2023, 31(1): 21-23. 

[8] Rha S Y, Lee H J, Lee J. Unmet needs in the physical and daily living domain mediates the influence of symptom experience on the quality of life of gastric cancer patients[J]. Support Care Cancer, 2020, 28(3): 1419-1431. 

[9] Kim H, Park S. Advances, breakthroughs, and challenges in gastric cancer surgery[J]. Chin J Cancer Res, 2023, 35(5): 433-437. 

[10] 艾飞玲 , 胡葵茹 , 石钰霖 , 等 . 基于纽卡斯尔 - 渥太华量表对中 国吸烟队列研究文献的质量评价 [J]. 中华疾病控制杂志 , 2021, 25(6): 722-729. 

[11] Dalhammar K, Malmström M, Sandberg M, et al. Health care utilization among patients with oesophageal and gastric cancer: the impact of initial treatment strategy and assignment of a contact nurse[J]. BMC Health Serv Res, 2021, 21(1): 1019. 

[12] Sivakumar J, Crosthwaite G. Prophylactic laparoscopic total gastrectomy in a patient with situs inversus totalis[J].J Surg Case Rep, 2021, 15(5): 475. 

[13] YAN C, SHAN F, YING X, et al. Global burden prediction of gastric cancer during demographic transition from 2020 to 2040[J]. Chin Med J (Engl), 2023, 136(4): 397-406. 

[14] Abbas M N, Bright T, Price T, et al. Patterns of care and outcomes for gastric and gastro-oesophageal junction cancer in an Australian population[J]. ANZ J Surg, 2021, 91(12): 2675-2682. 

[15] Abraham P, Wang L, Jiang Z, et al. Healthcare utilization and total costs of care among patients with advanced metastatic gastric and esophageal cancer[J]. Future Oncol, 2021, 17(3): 291-299. 

[16] 周英凤 , 钟婕 , 李丽 , 等 . 基于渥太华研究应用模式的妊娠期 糖尿病临床护理实践指南应用方案的构建 [J]. 护士进修杂志 , 2020, 35(9): 769-772, 776. 

[17] 丛悦 , 赵晓霜 , 李宏伟 , 等 . 基于渥太华研究应用模式的血管 导管相关感染预防方案及持续性效果评价 [J]. 中国护理管理 , 2022, 22(6): 813-818. 

[18] Naghashi S, Somi M H, Nikniaz Z. Pretreatment nutritional status is associated with quality of life in patients with gastric cancer: a cross-sectional study from Iran[J]. Support Care Cancer, 2022, 30(4): 3313-3319. 

[19] Taleghani F, Ehsani M, Farzi S, et al. Nutritional challenges of gastric cancer patients from the perspectives of patients, family caregivers, and health professionals: a qualitative study[J]. Support Care Cancer, 2021, 29(7): 3943-3950. 

[20] Vanderhout S, Nicholls S, Monfaredi Z, et al. Facilitating and supporting the engagement of patients, families and caregivers in research: the“Ottawa model”for patient engagement in research[J]. Res Involv Engagem, 2022, 8(1): 25. 

[21] Canny A, Mason B, Stephen J, et al. Advance care planning in primary care for patients with gastrointestinal cancer: feasibility randomised trial[J]. Br J Gen Pract, 2022, 72(721): e571-e580. 

[22] Hallet J, Look Hong N J, Zuk V, et al. Economic impacts of care by high-volume providers for non-curative esophagogastric cancer: a population-based analysis[J]. Gastric Cancer, 2020, 23(3): 373-381. 

[23] 刘晶晶 , 焦阳阳 , 吕贞贞 . 基于症状管理理论护理方案在胃 癌根治术患者中的应用 [J]. 国际护理学杂志 , 2023, 42(13): 2468-2472. 

[24] Moslim M A, Deng M, Handorf E, et al. Optimal care and survival for signet-ring cell and non-signet-ring cell gastric cancer are more achievable at academic cancer centers[J]. Am J Surg, 2021, 222(5): 969-975. 

[25] 陶伏莹 , 冯建萍 , 周元 , 等 . 基于渥太华研究应用模型的脑肿瘤 围手术期深静脉血栓预防证据应用审查及影响因素分析 [J]. 中 国实用护理杂志 , 2023, 39(5): 332-340.